Sanders Corazon (Corsee) D. 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Sanders Corazon (Corsee) D.
Director
Transactions
- Award
Common Stock
2024-06-18+5,345→ 12,593 total - Award
Stock Option (Right to Buy)
2024-06-18+9,900→ 9,900 totalExercise: $37.42Exp: 2034-06-18→ Common Stock (9,900 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.